MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of avai...
Change in fair value of warrant ...
Proceeds from exercise of stock ...
Non-cash lease expense
Negative Cash Flow Breakdown
Purchase of available-for-sale s...
Prepaid expenses and other asset...
Accounts payable, accrued expens...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-31,630
-39,025
-10,447
-17,459
Non-cash lease expense
85
83
81
79
Accretion of investment discounts
-295
-460
-321
-251
Stock-based compensation
3,154
2,202
2,465
2,428
Change in fair value of warrant liabilities
9,623
18,962
-10,532
-564
Deferred tax provision
-
-
5
-
Prepaid expenses and other assets
1,845
-12
-701
-805
Accounts payable, accrued expenses and other liabilities
-1,681
-4,300
4,038
566
Operating lease liabilities
-88
-86
-81
-81
Net cash used in operating activities
-22,677
-22,612
-14,091
-14,477
Purchase of available-for-sale short-term investments
16,263
43,122
69,223
32,655
Proceeds from maturities of available-for-sale short-term investments
39,500
49,078
48,761
45,060
Net cash provided by investing activities
23,237
5,956
-20,462
12,405
Proceeds from issuances of common stock and pre-funded warrants, net
-
-
53,577
-
Proceeds from exercise of stock options
91
-
115
0
Net cash provided by financing activities
91
-
53,692
0
Net change in cash and cash equivalents
651
-16,656
19,139
-2,072
Cash and cash equivalents at beginning of period
6,152
22,808
3,669
20,549
Cash and cash equivalents at end of period
6,803
6,152
22,808
3,669
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
of...
$39,500K
(-6.76%↓ Y/Y)
Proceeds from exercise of
stock options
$91K
Net cash provided by
investing activities
$23,237K
(55.35%↑ Y/Y)
Net cash provided by
financing activities
$91K
Canceled cashflow
$16,263K
Net change in cash
and cash...
$651K
(123.63%↑ Y/Y)
Canceled cashflow
$22,677K
Purchase of
available-for-sale short-term...
$16,263K
(-40.65%↓ Y/Y)
Change in fair value of
warrant liabilities
$9,623K
(143.05%↑ Y/Y)
Stock-based compensation
$3,154K
(17.07%↑ Y/Y)
Non-cash lease expense
$85K
(10.39%↑ Y/Y)
Net cash used in
operating activities
-$22,677K
(-28.02%↓ Y/Y)
Canceled cashflow
$12,862K
Net loss
-$31,630K
(-78.59%↓ Y/Y)
Prepaid expenses and
other assets
$1,845K
(86.55%↑ Y/Y)
Accounts payable,
accrued expenses and...
-$1,681K
(-137.17%↓ Y/Y)
Accretion of investment
discounts
-$295K
(31.71%↑ Y/Y)
Operating lease
liabilities
-$88K
(-14.29%↓ Y/Y)
Buy us a coffee
Eledon Pharmaceuticals, Inc. (ELDN)
Eledon Pharmaceuticals, Inc. (ELDN)